| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0006974> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0007131> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0024121> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0031960> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0242379> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C0252409> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C1449702> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C3640218> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C3642266> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C3853921> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C4060047> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34038226_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/C0443211_MENTIONED_IN_34038226>
?:authorAffiliation	[\'Department of Medical Oncology, University of Health Sciences, 146995Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Akkus_Mehmet_Hadi> <https://research.tib.eu/covid-19/entity/Dogan_Mutlu> <https://research.tib.eu/covid-19/entity/Kaman_Omur>
?:doi	<https://research.tib.eu/covid-19/entity/10.1177/10781552211020100>
?:doi	10.1177/10781552211020100
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Case_Reports> <https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34038226>
?:pmid	<https://research.tib.eu/covid-19/entity/34038226>
?:pmid	34038226
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0278252_PROCESS_OF_C1516213> <https://research.tib.eu/covid-19/entity/C3853921_COEXISTS_WITH_C0003451> <https://research.tib.eu/covid-19/entity/C3853921_COEXISTS_WITH_C1138226>
?:title	Alectinib continuation during COVID 19 \'antiviral\' treatment: Risk or benefit?
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34038226>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34038226>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all